You may feel like you’re going to die — but you’re not. Your body is right here in this safe place and we are monitoring you ...

Latest NHS statistics say 1,846,533 people aged 15-29 were prescribed antidepressants in 2023, compared with 1,404,138 in ...

A clinical LSD formulation shows promise for severe anxiety. Trials reveal meaningful symptom relief and limited side effects ...

As part of panel of experts convened by the U.S Food and Drug Administration (FDA), Case Western Reserve University professor Lee Hoffer voted last week to recommend a new nasal spray for ...

Herriot Tabuteau combined his Yale medical degree and two decades in finance to start Axsome Therapeutics. Now the company ...

A futuristic fix for depression is here — and it doesn’t involve prescription drugs or a shrink. The first-of-its-kind solution from GrayMatters Health uses something called “self-neuromodulation” to ...

Investors reacted positively to news that the company was using a $50 million private placement to help fund a Phase 3 study.

A recent study found that a single dose of LSD effectively treated symptoms of anxiety for an astonishing 12 weeks.

Frontline healthcare workers struggling with depression after the COVID-19 pandemic experienced significant relief from a ...

A new study suggests that a person’s genetic predisposition for chronic inflammation helps define a specific subtype of ...

A new large-scale analysis found that the short-term cardiovascular and metabolic side effects of antidepressants vary widely ...

The American Psychiatric Association offers a revamped approach to depression. Oct. 1, 2010— -- The American Psychiatric Association has issued an update to its 10-year-old treatment guidelines ...